Immediate Impact
1 by Nobel laureates 7 from Science/Nature 67 standout
Citing Papers
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
2023 Standout
Works of Catherine Fleener being referenced
Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential?
2019
The relationship of pharmacodynamics (PD) and pharmacokinetics (PK) to clinical outcomes in a phase I study of OX40 agonistic monoclonal antibody (mAb) PF-04518600 (PF-8600).
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Catherine Fleener | 223 | 178 | 93 | 162 | 25 | 595 | |
| Adam P. Curnock | 284 | 172 | 49 | 169 | 16 | 579 | |
| Katherine A. Rouleau | 219 | 151 | 88 | 175 | 17 | 544 | |
| Katrin Splith | 392 | 77 | 67 | 152 | 29 | 731 | |
| T Fujitsu | 127 | 164 | 20 | 98 | 18 | 619 | |
| M Dimitrijevic | 132 | 109 | 42 | 56 | 18 | 514 | |
| George Sukenick | 434 | 64 | 85 | 201 | 18 | 722 | |
| Gary A. Cain | 255 | 43 | 42 | 50 | 19 | 549 | |
| Brian Dunlap | 560 | 126 | 27 | 155 | 22 | 660 | |
| Wan‐Yun Huang | 151 | 32 | 78 | 143 | 48 | 721 | |
| Yannick Pilatte | 306 | 202 | 140 | 83 | 25 | 666 |
All Works
Loading papers...